Session Information
2012 Midyear Clinical Meeting
Click here to go to the previous page
Optimizing Antimicrobial Therapy for Gram-Negative Infections
Track:
Education Sessions (CE)
Program Code: 207-L01
Date: Thursday, December 6, 2012
Time: 2:30 PM to 4:00 PM EST
Location:
Mandalay Bay L, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Douglas Slain, PharmD, BCPS, Associate Professor & Infectious Diseases Clinical Specialist, West Virginia University
PROGRAM CHAIR:
Douglas Slain
Description
Optimizing Gram-Negative Therapy PK/PD, Marc H. Scheetz, PharmD, MSc
Combination Therapy for Gram-Negative Infections, Douglas Slain, PharmD, BCPS, FASHP
Combination Therapy for Gram-Negative Infections, Douglas Slain, PharmD, BCPS, FASHP
LEARNER OUTCOMES:
- Describe systematic approaches to implementing antimicrobial PK/PD dosing strategies in a clinical setting.
- Evaluate population pharmacokinetics/pharmacodynamics (PK/PD) modeling approaches used for dose optimization of antimicrobial therapy for Gram-negative infections.
- Explain the role of double coverage and/or combination therapy in empiric therapy.
- Identify clinical situations that would warrant double coverage of Gram-negative infections.
- List advantages to applying PK/PD principles in the treatment of Gram-negative infections specifically related to extended infusion -lactams.
This session is a part of:
This session is a part of: